Avadel Pharmaceuticals (AVDL)
8.63
0.58 (7.20%)
At close: Jan 15, 2025, 9:45 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 | FY97 | FY96 |
| Net Income | -160.28M | -137.46M | -77.33M | 7.03M | -33.23M | -95.30M | 67.25M | -41.28M | 40.66M | -84.91M | -42.92M | -3.23M | -8.77M | -8.97M | -11.44M | -12.08M | -37.74M | -35.20M | -27.38M | 12.50M | -3.49M | 3.00M | -2.87M | -9.46M | -6.69M | -7.81M | -6.80M | -6.90M |
| Depreciation & Amortization | 1.77M | 1.49M | 815.00K | 1.69M | 2.49M | 7.43M | 4.88M | 14.49M | 13.13M | 14.14M | 3.06M | 3.18M | 3.35M | 4.70M | 5.92M | 7.25M | 6.20M | 5.64M | 4.74M | 2.53M | 1.71M | 1.46M | 1.27M | 1.11M | 1.21M | 1.04M | 700.00K | 900.00K |
| Stock-Based Compensation | 15.81M | 7.01M | 8.87M | 3.00M | 519.00K | 7.85M | 8.07M | 14.68M | 7.74M | 2.69M | 2.03M | 3.04M | 2.78M | 3.17M | 5.50M | 8.29M | 9.99M | 546.00K | 1.39M | 1.39M | 23.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | 15.21M | 27.64M | -537.00K | -12.28M | -6.01M | -13.84M | 1.65M | 9.96M | 4.64M | 6.83M | -317.00K | -10.87M | -2.19M | -3.76M | 11.21M | -6.45M | 3.02M | -14.67M | 1.39M | -24.43M | 20.60M | 4.02M | -1.45M | 3.39M | 638.00K | -859.00K | -3.10M | 100.00K |
| Other Non-Cash Items | 17.19M | 8.09M | 2.30M | -44.88M | -4.02M | 28.17M | -69.53M | 33.70M | 26.15M | 52.03M | 30.18M | -12.68M | -8.77M | 3.17M | 5.50M | 8.29M | 11.69M | 10.00M | 546.00K | 967.00K | -575.00K | 18.00K | 23.00K | 20.00K | 74.00K | 95.00K | 200.00K | -11.10M |
| Deferred Income Tax | n/a | 26.02M | -15.67M | -7.43M | -6.33M | -19.15M | 3.56M | -4.00M | 1.42M | -2.81M | -11.32M | -4.76M | 5.50M | -4.20M | -8.17M | -9.97M | -11.24M | -2.16M | -5.13M | -1.39M | -23.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -3.00M | 24.54M | 3.69M | -8.13M | 2.25M | -11.71M | 2.42M | 1.31M | -4.81M | 8.23M | -1.70M | -8.69M | -4.39M | -3.32M | 10.89M | -9.27M | 1.87M | -8.66M | 6.44M | -20.15M | 14.58M | 4.29M | -1.20M | 2.71M | 1.17M | -1.51M | -3.00M | 12.90M |
| Operating Cash Flow | -128.51M | -70.30M | -77.31M | -48.73M | -38.33M | -82.72M | 16.66M | 18.90M | 84.29M | -10.62M | -20.68M | -23.14M | -10.32M | -5.46M | 8.20M | -7.51M | -19.24M | -29.83M | -19.39M | -4.15M | 12.23M | 8.77M | -2.78M | -5.62M | -4.24M | -8.19M | -8.90M | -4.20M |
| Capital Expenditures | n/a | -716.00K | -26.00K | -98.00K | -29.00K | -20.18M | -53.70M | -1.20M | -1.63M | -1.73M | -1.03M | -1.07M | -1.90M | -3.60M | -1.77M | -3.52M | -11.27M | -6.39M | -11.33M | -13.84M | -2.84M | -1.44M | -1.18M | -737.00K | -673.00K | -1.13M | -1.60M | -1.50M |
| Acquisitions | n/a | -80.41M | 16.50M | 25.50M | 154.00K | 20.00M | 53.11M | 628.00K | 779.00K | n/a | n/a | 1.77M | n/a | n/a | -327.00K | -327.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -237.23M | -3.41M | -61.77M | -131.41M | -24.65M | -376.31M | -151.00M | -107.60M | -50.59M | -68.28M | -1.08M | -3.57M | -25.02M | -73.63M | -160.97M | -70.78M | -96.71M | -183.61M | -424.38M | -22.57M | n/a | n/a | n/a | n/a | n/a | -4.24M | n/a | n/a |
| Sales Maturities Of Investments | 187.14M | 83.83M | 102.22M | 36.28M | 63.25M | 359.51M | 189.01M | 71.55M | 20.49M | 13.68M | 7.15M | 18.25M | 26.38M | 83.13M | 138.48M | 75.22M | 94.71M | 262.58M | 431.06M | 37.95M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 80.41M | 16.50M | 25.50M | 38.75M | -20.00M | -53.11M | -36.06M | -779.00K | 13.24M | 1.01M | 67.00K | 185.00K | 131.00K | 327.00K | 327.00K | 47.00K | 92.00K | 154.00K | 543.00K | 918.00K | 3.00K | 3.00K | n/a | 4.07M | 6.78M | n/a | -7.80M |
| Investing Cash Flow | -50.09M | 79.70M | 56.93M | -69.72M | 38.72M | -36.98M | -15.70M | -36.63M | -31.73M | -43.08M | 6.04M | 15.45M | -351.00K | 6.03M | -24.26M | 911.00K | -13.23M | 72.67M | -4.50M | 2.08M | -1.92M | -1.43M | -1.18M | -737.00K | 3.39M | 1.41M | -1.60M | -9.30M |
| Debt Repayment | -38.66M | n/a | n/a | n/a | n/a | 143.75M | n/a | n/a | -4.91M | -34.35M | 19.26M | 6.35M | 5.85M | -1.48M | 2.12M | 8.34M | 398.00K | -72.00K | 3.07M | 444.00K | -55.00K | 401.00K | -196.00K | -107.00K | -40.00K | -345.00K | n/a | -700.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -27.64M | -22.36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 27.94M | -10.78M | 263.00K | n/a | -145.00K | -1.12M | -1.36M | -8.39M | -25.83M | -1.92M | -1.38M | n/a | n/a | n/a | -4.00M | n/a | 2.06M | 2.94M | 4.36M | 3.88M | -997.00K | n/a | n/a | n/a | n/a | n/a | -100.00K | 100.00K |
| Financial Cash Flow | 135.34M | 14.54M | 263.00K | 179.68M | -27.00K | 112.66M | -23.32M | -7.95M | -23.75M | 96.00M | 18.27M | 6.96M | 6.14M | -774.00K | -1.58M | 8.88M | 3.02M | 5.48M | 21.08M | 5.09M | 74.43M | 402.00K | -196.00K | 11.62M | -40.00K | 9.85M | 600.00K | 27.90M |
| Net Cash Flow | -42.81M | 23.27M | -21.01M | 61.95M | 449.00K | -7.24M | -22.65M | -25.85M | 25.30M | 33.12M | 3.89M | -714.00K | -4.73M | -532.00K | -18.30M | 708.00K | -25.52M | 50.81M | -3.57M | 3.39M | 95.09M | 9.22M | -4.83M | 4.93M | -2.07M | 3.47M | -11.70M | 14.50M |
| Free Cash Flow | -128.51M | -71.02M | -77.34M | -48.83M | -38.35M | -102.89M | -37.04M | 17.70M | 82.66M | -12.35M | -21.70M | -24.21M | -12.23M | -9.06M | 6.42M | -11.03M | -30.51M | -36.22M | -30.71M | -17.99M | 9.39M | 7.34M | -3.96M | -6.36M | -4.91M | -9.32M | -10.50M | -5.70M |